Earnings and Growth Analysis : Electromed (NYSEAMERICAN:ELMD)

0
41

Earnings results for Electromed (NYSEAMERICAN:ELMD)

Electromed, Inc. is expected* to report earnings on 05/11/2021 after market close. The report will be for the fiscal Quarter ending Mar 2021. According to Zacks Investment Research, based on 2 analysts’ forecasts, the consensus EPS forecast for the quarter is $0.05. The reported EPS for the same quarter last year was $0.07.

Electromed last announced its quarterly earnings results on February 8th, 2021. The medical equipment provider reported $0.13 earnings per share for the quarter, beating analysts’ consensus estimates of $0.04 by $0.09. The company earned $9.50 million during the quarter, compared to analysts’ expectations of $8.25 million. Electromed has generated $0.47 earnings per share over the last year and currently has a price-to-earnings ratio of 23.9. Electromed has confirmed that its next quarterly earnings report will be published on Tuesday, May 11th, 2021.

Analyst Opinion on Electromed (NYSEAMERICAN:ELMD)

2 Wall Street analysts have issued ratings and price targets for Electromed in the last 12 months. Their average twelve-month price target is $18.00, predicting that the stock has a possible upside of 79.46%. The high price target for ELMD is $21.00 and the low price target for ELMD is $15.00. There are currently 2 buy ratings for the stock, resulting in a consensus rating of “Buy.”

Electromed has received a consensus rating of Buy. The company’s average rating score is 3.00, and is based on 2 buy ratings, no hold ratings, and no sell ratings. According to analysts’ consensus price target of $18.00, Electromed has a forecasted upside of 79.5% from its current price of $10.03. Electromed has only been the subject of 2 research reports in the past 90 days.

Dividend Strength: Electromed (NYSEAMERICAN:ELMD)

Electromed does not currently pay a dividend. Electromed does not have a long track record of dividend growth.

Insiders buying/selling: Electromed (NYSEAMERICAN:ELMD)

In the past three months, Electromed insiders have not sold or bought any company stock. Only 19.60% of the stock of Electromed is held by insiders. 37.50% of the stock of Electromed is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

Earnings and Valuation of Electromed (NYSEAMERICAN:ELMD

Earnings for Electromed are expected to grow by 88.00% in the coming year, from $0.25 to $0.47 per share. The P/E ratio of Electromed is 23.88, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 23.66. The P/E ratio of Electromed is 23.88, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 42.87. Electromed has a PEG Ratio of 4.12. PEG Ratios above 1 indicate that a company could be overvalued. Electromed has a P/B Ratio of 2.81. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

More latest stories: here